Literature DB >> 32988830

Structural Insights into Inhibition of the Acinetobacter-Derived Cephalosporinase ADC-7 by Ceftazidime and Its Boronic Acid Transition State Analog.

Brandy N Curtis1, Kali A Smolen1, Sara J Barlow1, Emilia Caselli2, Fabio Prati2, Magdalena A Taracila3,4, Robert A Bonomo5,4,6,7,8,9, Bradley J Wallar10, Rachel A Powers10.   

Abstract

Extended-spectrum class C β-lactamases have evolved to rapidly inactivate expanded-spectrum cephalosporins, a class of antibiotics designed to be resistant to hydrolysis by β-lactamase enzymes. To better understand the mechanism by which Acinetobacter-derived cephalosporinase-7 (ADC-7), a chromosomal AmpC enzyme, hydrolyzes these molecules, we determined the X-ray crystal structure of ADC-7 in an acyl-enzyme complex with the cephalosporin ceftazidime (2.40 Å) as well as in complex with a boronic acid transition state analog inhibitor that contains the R1 side chain of ceftazidime (1.67 Å). In the acyl-enzyme complex, the carbonyl oxygen is situated in the oxyanion hole where it makes key stabilizing interactions with the main chain nitrogens of Ser64 and Ser315. The boronic acid O1 hydroxyl group is similarly positioned in this area. Conserved residues Gln120 and Asn152 form hydrogen bonds with the amide group of the R1 side chain in both complexes. These complexes represent two steps in the hydrolysis of expanded-spectrum cephalosporins by ADC-7 and offer insight into the inhibition of ADC-7 by ceftazidime through displacement of the deacylating water molecule as well as blocking its trajectory to the acyl carbonyl carbon. In addition, the transition state analog inhibitor, LP06, was shown to bind with high affinity to ADC-7 (Ki , 50 nM) and was able to restore ceftazidime susceptibility, offering the potential for optimization efforts of this type of inhibitor.

Entities:  

Keywords:  Acinetobacter; Acinetobacter baumannii; boronic acid transition state analog inhibitor; ceftazidime; cephalosporinase; lactamase

Mesh:

Substances:

Year:  2020        PMID: 32988830      PMCID: PMC7674067          DOI: 10.1128/AAC.01183-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  36 in total

1.  Announcing the worldwide Protein Data Bank.

Authors:  Helen Berman; Kim Henrick; Haruki Nakamura
Journal:  Nat Struct Biol       Date:  2003-12

2.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

3.  Inhibition of Acinetobacter-Derived Cephalosporinase: Exploring the Carboxylate Recognition Site Using Novel β-Lactamase Inhibitors.

Authors:  Emilia Caselli; Chiara Romagnoli; Rachel A Powers; Magdalena A Taracila; Alexandra A Bouza; Hollister C Swanson; Kali A Smolen; Francesco Fini; Bradley J Wallar; Robert A Bonomo; Fabio Prati
Journal:  ACS Infect Dis       Date:  2017-12-08       Impact factor: 5.084

4.  Structures of ceftazidime and its transition-state analogue in complex with AmpC beta-lactamase: implications for resistance mutations and inhibitor design.

Authors:  R A Powers; E Caselli; P J Focia; F Prati; B K Shoichet
Journal:  Biochemistry       Date:  2001-08-07       Impact factor: 3.162

5.  Structure of the extended-spectrum class C beta-lactamase of Enterobacter cloacae GC1, a natural mutant with a tandem tripeptide insertion.

Authors:  G V Crichlow; A P Kuzin; M Nukaga; K Mayama; T Sawai; J R Knox
Journal:  Biochemistry       Date:  1999-08-10       Impact factor: 3.162

Review 6.  The rise of carbapenem-resistant Acinetobacter baumannii.

Authors:  Benjamin A Evans; Ahmed Hamouda; Sebastian G B Amyes
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

7.  Enhancing resistance to cephalosporins in class C beta-lactamases: impact of Gly214Glu in CMY-2.

Authors:  Andrea Endimiani; Yohei Doi; Christopher R Bethel; Magdalena Taracila; Jennifer M Adams-Haduch; Alexandra O'Keefe; Andrea M Hujer; David L Paterson; Marion J Skalweit; Malcolm G P Page; Sarah M Drawz; Robert A Bonomo
Journal:  Biochemistry       Date:  2010-02-09       Impact factor: 3.162

8.  Structure of AmpC beta-lactamase (AmpCD) from an Escherichia coli clinical isolate with a tripeptide deletion (Gly286-Ser287-Asp288) in the H10 helix.

Authors:  Yoshihiro Yamaguchi; Genta Sato; Yuriko Yamagata; Yohei Doi; Jun-ichi Wachino; Yoshichika Arakawa; Koki Matsuda; Hiromasa Kurosaki
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-05-22

9.  Structure of the extended-spectrum class C β-lactamase ADC-1 from Acinetobacter baumannii.

Authors:  Monolekha Bhattacharya; Marta Toth; Nuno Tiago Antunes; Clyde A Smith; Sergei B Vakulenko
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-02-22

10.  Biochemical and structural analysis of inhibitors targeting the ADC-7 cephalosporinase of Acinetobacter baumannii.

Authors:  Rachel A Powers; Hollister C Swanson; Magdalena A Taracila; Nicholas W Florek; Chiara Romagnoli; Emilia Caselli; Fabio Prati; Robert A Bonomo; Bradley J Wallar
Journal:  Biochemistry       Date:  2014-11-25       Impact factor: 3.162

View more
  1 in total

Review 1.  Class C β-Lactamases: Molecular Characteristics.

Authors:  Alain Philippon; Guillaume Arlet; Roger Labia; Bogdan I Iorga
Journal:  Clin Microbiol Rev       Date:  2022-04-18       Impact factor: 50.129

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.